Financial comparisons Seelos Therapeutics, Inc.
Stocks
SEELQ
US81577F4063
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
12:25:32 2026-06-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | +9,900.00% |
| 12-28 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 25-10-21 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 6.5B | 42.13% | 52.64% | 28.56% | 20.88% | -0.99x | |
| 4.25B | 30.41% | 24.81% | 20.15% | 17.36% | -3.18x | |
| 8.24B | 14.53% | 21.7% | 10.28% | 4.9% | 1.58x | |
| 16.31B | 8.34% | 13.38% | 32.9% | 4.79% | 3.63x | |
| 5.34B | 5.37% | 8.37% | 29.84% | 16.27% | -5.99x | |
| 2.88B | 24.74% | 28.07% | 5.94% | 4.75% | 1.77x | |
| 3.12B | 22.53% | 31.44% | 11.9% | 8.13% | -1.19x | |
| 606M | -210.54% | -205.59% | -249.28% | - | 0.72x | |
| 3.37B | -39.59% | -48.95% | -5.88% | -5.1% | 6.99x | |
| 3.69B | 25.89% | 28.63% | 17.53% | 9.99% | -1.51x | |
| 2.53B | 17.83% | 20.93% | 70.23% | 22.13% | -0.89x | |
| 498M | 32.27% | 31.52% | 16.97% | 14.74% | -3.83x | |
| 8.57B | 6.51% | 14.79% | 9.61% | 4.34% | 2.22x | |
| 846M | -31.67% | -18.92% | - | - | 1.57x | |
| 1.27B | -19.27% | -3.71% | -38.64% | -6.61% | -65.61x | |
| 2.32B | 33.73% | 37.59% | 35.53% | 27.02% | -1.18x | |
| 294M | -18.56% | -24.05% | -9.34% | -9.05% | 8.22x | |
| 4.02B | -3.59% | 19.77% | 15.46% | 6.99% | 1.98x | |
| Average | 4.15B | -3.27% | 1.8% | 0.1% | 8.85% | -3.09x | |
| Weighted average by Cap. | 5.28B | 4.04% | 8.51% | 5.08% | 10.63% | -1.86x |
- Stock Market
- Stocks
- SEELQ Stock
- Sector Seelos Therapeutics, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
